Kushtrim Kryeziu

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapy.

Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapy.

Journal: Cancer treatment reviews

Published: May 01, 2026

Exceptional treatment responses and molecular markers among 103 colorectal cancer cell lines.

Exceptional treatment responses and molecular markers among 103 colorectal cancer cell lines.

Journal: Molecular biomedicine

Published: April 10, 2026

Patient-derived organoids from metastatic colorectal cancer mirror tumor heterogeneity and predict patient survival and drug sensitivity.

Patient-derived organoids from metastatic colorectal cancer mirror tumor heterogeneity and predict patient survival and drug sensitivity.

Journal: Cell reports. Medicine

Published: December 11, 2025

Molecular prognostic factors for liver transplantation of unresectable metastatic colorectal cancer.

Molecular prognostic factors for liver transplantation of unresectable metastatic colorectal cancer.

Journal: The British journal of surgery

Published: December 19, 2024

Co-occurring mutations identify prognostic subgroups of microsatellite stable colorectal cancer.

Co-occurring mutations identify prognostic subgroups of microsatellite stable colorectal cancer.

Journal: Molecular cancer

Published: October 02, 2024

Endocytic trafficking of connexins in cancer pathogenesis.

Endocytic trafficking of connexins in cancer pathogenesis.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: February 06, 2023

A novel EGFR inhibitor acts as potent tool for hypoxia-activated prodrug systems and exerts strong synergistic activity with VEGFR inhibition in vitro and in vivo.

A novel EGFR inhibitor acts as potent tool for hypoxia-activated prodrug systems and exerts strong synergistic activity with VEGFR inhibition in vitro and in vivo.

Journal: Cancer letters

Published: January 31, 2023

The E3 ubiquitin ligase ITCH negatively regulates intercellular communication via gap junctions by targeting connexin43 for lysosomal degradation.

The E3 ubiquitin ligase ITCH negatively regulates intercellular communication via gap junctions by targeting connexin43 for lysosomal degradation.

Journal: Cellular and molecular life sciences : CMLS

Published: January 10, 2023

Multiplex immunohistochemistry of metastatic colorectal cancer and ex vivo tumor avatars.

Multiplex immunohistochemistry of metastatic colorectal cancer and ex vivo tumor avatars.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: January 22, 2022

Increased sensitivity to SMAC mimetic LCL161 identified by longitudinal ex vivo pharmacogenomics of recurrent, KRAS mutated rectal cancer liver metastases.

Increased sensitivity to SMAC mimetic LCL161 identified by longitudinal ex vivo pharmacogenomics of recurrent, KRAS mutated rectal cancer liver metastases.

Journal: Journal of translational medicine

Published: June 28, 2021

The expressed mutational landscape of microsatellite stable colorectal cancers.

The expressed mutational landscape of microsatellite stable colorectal cancers.

Journal: Genome medicine

Published: January 06, 2021

Molecular correlates of sensitivity to PARP inhibition beyond homologous recombination deficiency in pre-clinical models of colorectal cancer point to wild-type TP53 activity.

Molecular correlates of sensitivity to PARP inhibition beyond homologous recombination deficiency in pre-clinical models of colorectal cancer point to wild-type TP53 activity.

Journal: EBioMedicine

Published: February 11, 2020

Showing 1-12 of 29

Last Updated: 09/26/2026